Upcoming Events
Log In
Pricing
Free Trial

Diffusion Characteristics of AML

HIDE
PrevNext

0:00

Dr. P here with our 72 year old lady with a

0:01

3 00:00:03,270 --> 00:00:06,479 4 centimeter greater AML or angiomyolipoma.

0:06

I want to talk a little bit about diffusion

0:09

imaging and this disorder and mass.

0:12

This is going to be a little bit of an

0:13

opinion piece because the jury is still out.

0:17

But let's talk just briefly about

0:18

the causes of diffusion restriction.

0:22

And they include, let me get something easy to

0:24

draw with here, like yellow. We've got desmoplasia.

0:28

Firmness can produce diffusion restriction.

0:32

Then we've got cellularity.

0:35

This is a very important one, so

0:36

something like lymphoma, very tightly

0:39

packed cells, cytoplasmic-poor lesions.

0:43

Then we've got something like viscosity.

0:45

Examples of that would be hemorrhage,

0:48

an epidermoid, an abscess.

0:51

Then you've got cell death.

0:54

An example of that would be like an infarct.

0:56

We see that in the brain all the time

0:58

with loss of the cell wall.

1:00

And then you've got something like necrotization.

1:03

And, uh, necrotization, I won't spell

1:07

it all out because I'm a bad speller.

1:09

Here we go.

1:10

Necrotization, not so good on the spelling.

1:13

At any rate, necrotization occurs.

1:15

Let's say somebody has, uh, heroin poisoning

1:18

and they have a necrotizing lesion in the brain.

1:20

That can do it as well.

1:22

And you could also do it with destruction in the

1:24

brain from, say, a slow acting viral infection.

1:26

So that gives you some of the some of the

1:29

causes of diffusion restriction, and now you

1:31

can extrapolate and apply these into the body

1:34

from the neural axis.

1:36

I have on the left a series of diffusion images

1:40

where the B value, in other words, the intensity

1:43

of diffusion restriction, has been ramped up

1:45

from a B value of 0 to a B value of around 1000.

1:50

And we're going to go through the

1:51

same locus of our angiomyolipoma.

1:54

Here it is.

1:55

There's the rest of the kidney.

1:56

Here's our AML on the right, on a T1 emphasized image.

2:00

It's got lots of fat inside it.

2:02

And here's the rest of the kidney.

2:03

Now let's watch as we raise the B values so

2:07

that we're more heavily diffusion restricted.

2:10

There's this little focus right

2:11

here anteriorly in our AML.

2:13

Let's keep looking.

2:15

And it persists, but not inordinately so.

2:18

So what does that mean?

2:20

You know, there's some mild diffusion restriction.

2:22

There are about three or four of

2:23

these loci or spots about like this.

2:26

A few of them were a little bit brighter.

2:28

So I would say mild to moderate diffusion restriction.

2:32

So what's the bottom line?

2:34

Because I inferred earlier in a prior vignette that

2:37

the absence of diffusion restriction favors an AML.

2:40

Well, we know that AMLs can

2:42

diffusion restrict, and why?

2:44

Because they've got some pretty tight

2:46

packing of smooth muscle tissue.

2:48

You know, one cell right next to the

2:49

other without a lot of cytoplasm.

2:51

And there are other reasons as well.

2:54

So AMLs can, and sometimes do,

2:56

show diffusion restriction.

2:58

But if I have really pronounced diffusion

3:00

restriction in large areas of interest,

3:03

then I go for renal cell carcinoma.

3:06

If I have no diffusion restriction

3:08

at all, it doesn't help you much.

3:10

But it certainly would move you more towards a

3:12

benign lesion and excluding some of these other

3:15

things that we've discussed like desmoplasia,

3:18

cellularity, viscosity, cell death, and

3:22

necrotizing, uh, disturbance of, of tissue.

3:26

So the bottom line is, diffusion restriction right

3:29

now, not inordinately helpful unless you have

3:32

extremes of large diffusion restricted areas on one

3:36

end and no diffusion restriction on the other end.

3:40

Let's move on, shall we?

3:41

Dr. P out.

Report

Faculty

Stephen J Pomeranz, MD

Chief Medical Officer, ProScan Imaging. Founder, MRI Online

ProScan Imaging

Tags

Vascular

Non-infectious Inflammatory

Neoplastic

MRI

Kidneys

Genitourinary (GU)

Body

© 2024 Medality. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy